Imed Infinity Medical-Limited Partnership
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. Imed Infinity Medical-Limited Partnership was incorporated in 2020 and is based in Tel Aviv, Israel.
Imed Infinity Medical-Limited Partnership (IMED) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.025x
Based on the latest financial reports, Imed Infinity Medical-Limited Partnership (IMED) has a cash flow conversion efficiency ratio of -0.025x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-213.00K) by net assets (ILA8.44 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Imed Infinity Medical-Limited Partnership - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Imed Infinity Medical-Limited Partnership's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Imed Infinity Medical-Limited Partnership Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Imed Infinity Medical-Limited Partnership ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Simteract S.A.
WAR:SMT
|
N/A |
|
Lake Superior Acquisition Corp. Rights
NASDAQ:LKSPR
|
N/A |
|
XINYI GLASS HLDGS (XI9.SG)
STU:XI9
|
N/A |
|
Easson Holdings Ltd
PA:MLEAS
|
N/A |
|
Global Gaming Technologies Corp
PINK:BLKCF
|
0.000x |
|
Genesis Healthcare Inc
PINK:GENN
|
0.049x |
|
UR-ENERGY
MU:U9T
|
-0.045x |
|
Bebop Channel Corp
PINK:BBOP
|
N/A |
Annual Cash Flow Conversion Efficiency for Imed Infinity Medical-Limited Partnership (2020–2024)
The table below shows the annual cash flow conversion efficiency of Imed Infinity Medical-Limited Partnership from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA7.54 Million | ILA-639.00K | -0.085x | -12.93% |
| 2023-12-31 | ILA8.11 Million | ILA-609.00K | -0.075x | +42.75% |
| 2022-12-31 | ILA9.88 Million | ILA-1.30 Million | -0.131x | -58.14% |
| 2021-12-31 | ILA10.89 Million | ILA-903.00K | -0.083x | -508.29% |
| 2020-12-31 | ILA11.62 Million | ILA236.00K | 0.020x | -- |